NY-SECURITYSCORECARD
12.9.2022 10:02:00 CEST | Business Wire | Press release
Leading IT services provider NTT DATA UK&I and SecurityScorecard, the global leader in cyber security ratings, today announced a new partnership to accelerate the transformation of continuous cyber risk monitoring across industries across the UK and Ireland (UK&I). As part of the partnership, NTT DATA will deliver an innovative posture evaluation report offering for clients, based on the SecurityScorecard platform. The report will combine NTT DATA’s consulting expertise with SecurityScorecard’s ratings and assessment capabilities to instantly rate, analyse and continuously monitor security risk for clients, as well as harden their security postures.
In today’s ever-evolving cyber security landscape, organisations must be proactive in addressing cyber breaches, and security ratings are integral to measuring and understanding resilience in real time. NTT DATA understands the importance of this and is doubling its efforts in the cyber security space as a result, ensuring its clients are best equipped to handle new threats on a regular basis. It is for this reason that SecurityScorecard has joined the likes of Adobe and Microsoft in becoming a Tier 1 strategic partner for NTT DATA UK&I.
From non-executive directors through to IT operations teams, businesses’ stakeholders call out three critical board-level risks – data loss, cyber breach, and third-party exposure. These risks are typically grounded in common challenges, such as enterprise visibility, poor information clarity or translation, and confused response prioritisation, but are stressed further by an industry-wide shortage of competent security knowledge and skills. The partnership between NTT DATA and SecurityScorecard will address these client challenges head-on, bringing together industry-leading core competencies, industry sector insights, deep client knowledge, and strategic client relationships.
Mike Jones, VP of Partners & Alliances at NTT DATA (UK&I), commented: “NTT DATA is proud of its global ecosystem of Partners & Alliances, which helps bring value to our clients through transformational change. We’re delighted to announce our latest partnership with SecurityScorecard, the global leader in cybersecurity ratings, to help NTT DATA identify security threats as well as keep clients safe and secure.”
SecurityScorecard provides comprehensive security ratings, automated assessments, and guidance from industry experts, providing easy-to-understand A-F graded scorecards for improved communication, effective compliance reporting and more informed decision making. The solution allows organisations to automate and accelerate questionnaire exchange with over 20 compliance survey templates and questionnaires at scale.
“Our partnership with NTT DATA immediately gives customers in EMEA more complete visibility into the risks that exist in their environment, and guidance in reducing that risk most effectively, all in a single platform,” said Jan Bau, VP EMEA and LATAM at SecurityScorecard. “This will enable organisations across NTT DATA’s portfolio to proactively ensure they have continuous and immediate insights on their security posture.”
Through the partnership, SecurityScorecard will embed a suite of cyber security monitoring solutions into NTT DATA’s managed service offering to create a monthly posture evaluation report. The report will allow businesses to understand their true cyber risk and will enable them to instantly improve their security postures through much-needed data, visibility, and insights. As well as insights from the platform, the monthly service will benefit from NTT DATA’s advisory and threat intelligence capabilities, providing not just an overview of a client’s industry sector, but an overview of their vendors and business partners as well, delivering additional value to clients in the areas they want to target the most.
Jones added, “NTT DATA places huge importance on cyber resilience and our new posture evaluation solution has been built to provide our clients with peace of mind when it comes to their cyber security. Not only will our reporting tool share a holistic overview of their security measures, but clients will be able to rest easy knowing they have identified all potential areas of vulnerability and implemented the right solutions to protect their critical infrastructure.”
For more information about SecurityScorecard and NTT DATA UK&I, visit the SecurityScorecard booth at the Gartner UK Security & Risk Summit, Stand 105 from September 12 through the 14.
About NTT DATA
NTT DATA is the world’s second largest managed security services provider, with over 5,500 information and cyber security professionals globally. Headquartered in Tokyo, and with business operations in over 50 countries, NTT DATA’s security practice provides Security Consulting, Engineering, Managed Services and accelerated partnered product solutions that align with its clients’ business goals, as well as meet speed, cost, quality, and regulatory needs. NTT DATA’s emphasis is on long-term commitment, combining Security Operations Centres (SOCs) and local delivery capabilities to provide premier professional services on a global scale. For more information, visit: uk.nttdata.com
About SecurityScorecard
Funded by world-class investors including Evolution Equity Partners, Silver Lake Waterman, Sequoia Capital, GV, Riverwood Capital, and others, SecurityScorecard is the global leader in cybersecurity ratings with more than 12 million companies continuously rated. Founded in 2013 by security and risk experts Dr. Aleksandr Yampolskiy and Sam Kassoumeh, SecurityScorecard's patented rating technology is used by over 30,000 organisations for enterprise risk management, third-party risk management, board reporting, due diligence, cyber insurance underwriting, and regulatory oversight. SecurityScorecard is the first cybersecurity ratings company to offer digital forensics and incident response services, providing a 360-degree approach to security prevention and response for its worldwide customer and partner base. SecurityScorecard continues to make the world a safer place by transforming the way companies understand, improve and communicate cybersecurity risk to their boards, employees and vendors. Every organisation has the universal right to their trusted and transparent Instant SecurityScorecard rating. For more information, visit securityscorecard.com or connect with us on LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220912005192/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Strongest Half-Year in Curatis’s History — Revenue up 51% and Significant Progress on Corticorelin (C-PTBE-01)21.9.2026 07:03:00 CEST | Press release
Curatis Holding AG (SIX:CURN, “Curatis”) reports net sales from goods and services of CHF 7.9m for the first half of 2026, up 51% (H1 2025: CHF 5.2m), with the loss for the period narrowing to CHF -0.4m (H1 2025: CHF -1.2m) and cash and cash equivalents rising to CHF 3.6m (31 December 2025: CHF 1.9m). Curatis also advanced its corticorelin (C-PTBE-01) program on multiple levels, including an exclusive Japan licence with Neupharma and continued manufacturing progress. Business development and finances Net sales from goods increased by 46% to CHF 7.4m (H1 2025: CHF 5.0m) and net sales from services rose to CHF 0.6m (H1 2025: CHF 0.2m). Growth was driven both by products marketed for some time and by products added to the distribution portfolio in 2025 and 2026. The gross contribution from goods and services rose by 32% to CHF 1.8m (H1 2025: CHF 1.3m); the combined cost base grew by only 9% against net sales growth of 51%, as personnel expenses rose 5% to CHF 1.3m (H1 2025: CHF 1.2m) and
Galderma Begins Trading in the Swiss Market Index, Joining Switzerland's Leading Blue Chip Companies21.9.2026 07:00:00 CEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today begins trading as a constituent of the Swiss Market Index (SMI), Switzerland's leading blue chip equity benchmark comprising 20 of the country's largest and most liquid listed companies. Less than three years after its IPO on the SIX Swiss Exchange in March 2024, Galderma has established itself as one of Switzerland's leading listed companies. Its inclusion in the SMI reflects the company's strong growth, disciplined execution and increasing relevance in Swiss and international capital markets as it advances its ambition to become the world's leading dermatology powerhouse. Since its IPO, Galderma has continued to execute its growth-focused integrated dermatology strategy, delivering strong performance across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Net sales increased from 4.410 billion USD in 2024 to 5.207 billion USD in 2025, driven by science-led innovation, portfolio and geogr
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
